|
|
1.
|
Non-Culprit MACE Rate in LRP: The Influence of Optimal Medical Therapy Using DAPT and Statins. Non-culprit MACE-rate in LRP: The influence of optimal medical therapy using DAPT and statins. MedStar authors:
- Garcia-Garcia, Hector M
- Mintz, Gary S
- Waksman, Ron
Year: 2022
Citation: - Cardiovascular Revascularization Medicine. 37:92-96, 2022 Apr.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ali ZA, Artis A, de Winter RJ, Di Mario C, Garcia-Garcia HM, Mintz GS, Renkens MPL, Singh V, Skinner W, Ten Cate T, Torguson R, Waksman R, Wykrzykowska JJ
|
|
|
2.
|
The IMPact on Revascularization Outcomes of intraVascular ultrasound-guided treatment of complex lesions and Economic impact (IMPROVE) trial: Study design and rationale. MedStar authors:
- Garcia-Garcia, Hector M
- Mintz, Gary S
- Shlofmitz, Evan
- Torguson, Rebecca
- Waksman, Ron
- Weintraub, William S
- Zhang, Cheng
Year: 2020
Citation: - American Heart Journal. 228:65-71, 2020 10.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Di Mario C, Garcia-Garcia HM, Hodgson JM, Inderbitzen B, Kumar G, Mintz GS, Shah B, Sharp A, Shlofmitz E, Singh J, Torguson R, Waksman R, Weintraub WS, Zhang C
|
